homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

February 26, 2019

Immune Design

Merck is buying Immune Design for $300 million. Immune Design is a late-stage immunotherapy company using in vivo approaches to enable the body's immune system to fight disease. It has offices in Seattle and San Francisco. The deal is expected to close this spring.




Email or user name:
Password:
 
Forgot password? Click here.